BackRubius Therapeutics Overview

Rubius Therapeutics Property, Plant & Equipment

Latest property, plant & equipment for RUBY: $2.8M.

Get informed when a big investor buys or sells

+ Follow
PPE
$2.83M
96.74% YoYΔ $-83.80M vs prior year quarter

Peer average / median

Loading

Rubius Therapeutics PPE History

Loading

Rubius Therapeutics vs. peers: PPE Comparison

Loading

Rubius Therapeutics PPE Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rubius Therapeutics (RUBY) FAQ

As of the most recent data (December 2022), RUBY shows a PP&E of $2.8M. That compares with $87M in the prior-year period — down 96.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RUBY's PP&E is now $2.8M (was $87M) — a 96.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rubius Therapeutics is outperforming or lagging.

Tracking RUBY's property, plant & equipment over time shows whether Rubius Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.8M That compares with $87M in the prior-year period — down 96.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this property, plant & equipment page, Stockcircle has Rubius Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PP&E (currently $2.8M) with ownership activity and broader fundamentals.

Rubius Therapeutics's PP&E is $2.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.